Skip to content

Clinical trials

Observational Coronary Artery Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Observational Country / region: Canada Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20073
20086
20092
20104
20112
20127
20136
20145
20151
20162
20174
20184
20192
20202
20213
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Unknown status12
Recruiting5
Not yet recruiting2
Active, not recruiting2
Withdrawn1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McGill University Health Centre/Research Institute of the McGill University Health Centre5
Ottawa Heart Institute Research Corporation5
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
University of Calgary3
Abbott Medical Devices2
Brigham and Women's Hospital2
Hamilton Health Sciences Corporation2
Innovaderm Research Inc.2
Laval University2
MDDX LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease61
Cardiovascular Diseases6
Atherosclerosis5
Myocardial Infarction5
Angina Pectoris4
Diabetes Mellitus4
Heart Failure4
Myocardial Ischemia4
Heart Diseases3
Stroke3

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.